Finzati - Logo
NTRB logo

Nutriband Inc.

NTRBBiotechnology
$5.97
+0.34 (+6.04%)
Current price
EarningsLatest report: Apr 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$37.81M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 6.36Negative growth trendWeak profitability
Financial data as of: Apr 30, 2026, 12:00 AM UTCLast earnings update: Jun 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$5.97
Change6.04%
Market Cap$37.81M
52W Range2.90 - 11.68
Beta1.93
Gross Margin25.68%
Oper. Margin-4.08%
Profit Margin-4.04%
Debt/Eq0.03
Current Ratio6.36
Quick Ratio6.21
Volume18.60K

Investment DNA

How strong this company looks for long-term investors

30
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
27/100
Why this score
Manageable debt level · 0.03Healthy liquidity · 6.36Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 10/1/2021
Industry: Biotechnology
P/B i: 8.35
Debt / Equity i: 0.03
Operating Margin: -408.41%
Net Margin: -404.08%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.03
Current Ratio: 6.36
Quick Ratio: 6.21
Status: Good

Insider Transactions

Recent executive and insider activity

Sheridan Gareth
Transaction: 01/31/2025
OTHER
Change
0
Price
Not reported
Filing
11/25/2025
Type
OTHER
Sheridan Gareth
Transaction: 01/29/2025
BUY
Change
+29,333
Price
$8.07
Filing
11/25/2025
Type
BUY
Sheridan Gareth
Transaction: 03/20/2024
BUY
Change
+97,500
Price
$2.61
Filing
11/25/2025
Type
BUY